Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

I agree this could be a template for a future deal. If Brilacidin does become the Covid19 antiviral drug of choice it will be worth much more than OncoImmune's CD24Fc and Gilead's Remdesivir.

Remdesivir brought in almost 2 billion dollars last quarter. A lot of money for a drug many clinicians and the WHO says doesn't work or at best is mildly effective.

"Remdesivir, which is sold under the brand name Veklury, brought in $1.9 billion in the fourth quarter ended Dec. 31, above analysts’ estimates of $1.34 billion. Excluding Veklury, Gilead said its quarterly sales fell 7%."

"For 2021, the California-based company projected an adjusted earnings range with a midpoint of $7.10 per share, on product sales with a midpoint of $24.4 billion, ahead of respective Wall Street estimates of $6.85 per share and $24.27 billion, according to IBES data from Refinitiv."

https://www.reuters.com/article/us-gilead-sciences-results/gilead-forecasts-2021-growth-strong-remdesivir-covid-19-sales-idUSKBN2A42V7

https://www.bmj.com/content/371/bmj.m4057